These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24835292)

  • 1. Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer.
    Hoon DS; Bernet L; Cano R; Viale G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):180-92. PubMed ID: 24835292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.
    Espinosa-Bravo M; Sansano I; Pérez-Hoyos S; Ramos M; Sancho M; Xercavins J; Rubio IT; Peg V
    Eur J Surg Oncol; 2013 Jul; 39(7):766-73. PubMed ID: 23607911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The real-time intra-operative evaluation of sentinel lymph nodes in breast cancer patients using One Step Nucleic Acid Amplification (OSNA) and implications for clinical decision-making.
    Chaudhry A; Williams S; Cook J; Jenkins M; Sohail M; Calder C; Winters ZE; Rayter Z
    Eur J Surg Oncol; 2014 Feb; 40(2):150-7. PubMed ID: 24378008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical application of the one-step nucleic acid amplification method to detect sentinel lymph node metastasis in breast cancer.
    Sagara Y; Ohi Y; Matsukata A; Yotsumoto D; Baba S; Tamada S; Sagara Y; Matsuyama Y; Ando M; Rai Y; Sagara Y
    Breast Cancer; 2013 Apr; 20(2):181-6. PubMed ID: 22203582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.
    Babar M; Madani R; Jackson P; Layer GT; Kissin MW; Irvine TE
    Surgeon; 2016 Apr; 14(2):76-81. PubMed ID: 25444440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
    Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
    Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.
    Peg V; Espinosa-Bravo M; Vieites B; Vilardell F; Antúnez JR; de Salas MS; Delgado-Sánchez JJ; Pinto W; Gozalbo F; Petit A; Sansano I; Del Mar Téllez M; Rubio IT
    Breast Cancer Res Treat; 2013 May; 139(1):87-93. PubMed ID: 23576079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
    Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
    J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of whole sentinel lymph node analysis by one-step nucleic acid amplification for intraoperative diagnosis of breast cancer metastases.
    Castellano I; Macrì L; Deambrogio C; Balmativola D; Bussone R; Ala A; Coluccia C; Sapino A
    Ann Surg; 2012 Feb; 255(2):334-42. PubMed ID: 21975319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
    Tvedskov TF
    Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of metastatic breast cancer in non-sentinel lymph nodes based on metalloprotease-1 expression by the sentinel lymph node.
    Eiró N; González LO; Atienza S; González-Quintana JM; Beridze N; Fernandez-Garcia B; Pérez-Fernández R; García-Caballero T; Schneider J; Vizoso FJ
    Eur J Cancer; 2013 Mar; 49(5):1009-17. PubMed ID: 23063352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy.
    Navarro-Cecilia J; Dueñas-Rodríguez B; Luque-López C; Ramírez-Expósito MJ; Martínez-Ferrol J; Ruíz-Mateas A; Ureña C; Carrera-González MP; Mayas MD; Martínez-Martos JM
    Eur J Surg Oncol; 2013 Aug; 39(8):873-9. PubMed ID: 23711734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of molecular analysis and histopathology for axillary lymph node staging in primary breast cancer: results of the B-CLOSER-I study.
    Vegué LB; Rojo F; Hardisson D; Iturriagagoitia AC; Panadés MJ; Velasco A; Bonet EL; Muñoz RC; Polo L;
    Diagn Mol Pathol; 2012 Jun; 21(2):69-76. PubMed ID: 22555089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.
    Nabais C; Figueiredo J; Lopes P; Martins M; Araújo A
    Breast; 2017 Apr; 32():33-36. PubMed ID: 28030783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay.
    Tamaki Y; Akiyama F; Iwase T; Kaneko T; Tsuda H; Sato K; Ueda S; Mano M; Masuda N; Takeda M; Tsujimoto M; Yoshidome K; Inaji H; Nakajima H; Komoike Y; Kataoka TR; Nakamura S; Suzuki K; Tsugawa K; Wakasa K; Okino T; Kato Y; Noguchi S; Matsuura N
    Clin Cancer Res; 2009 Apr; 15(8):2879-84. PubMed ID: 19351770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer.
    Deambrogio C; Castellano I; Paganotti A; Zorini EO; Corsi F; Bussone R; Franchini R; Antona J; Miglio U; Sapino A; Antonacci C; Boldorini R
    J Clin Pathol; 2014 Aug; 67(8):702-6. PubMed ID: 24906358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.
    Osako T; Iwase T; Kimura K; Horii R; Akiyama F
    Eur J Cancer; 2013 Apr; 49(6):1187-95. PubMed ID: 23265708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.
    Rubio IT; Espinosa-Bravo M; Rodrigo M; Amparo Viguri Diaz M; Hardisson D; Sagasta A; Dueñas B; Peg V
    Breast Cancer Res Treat; 2014 Sep; 147(2):371-80. PubMed ID: 25164972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.